Cultured CD71+ erythroid cells modulate the host immune response

Transfus Med. 2023 Jun;33(3):257-262. doi: 10.1111/tme.12964. Epub 2023 Mar 15.

Abstract

Objective: The study aimed to determine the impact of Red Blood Cells (RBCs) generated from peripheral blood mononuclear cells (PBMCs) on T cell proliferation and host response following whole blood stimulation.

Background: Culturing RBCs is a potential solution for donor shortage. The impact of immature cultured RBCs which express CD71+ on host immune response is not known.

Methods/materials: PBMCs were seeded in an erythroid expansion medium. CD71+ cells were isolated at days 14 and 21 of culture and incubated with either purified T cells or with LPS-stimulated whole blood. Controls were incubated with medium.

Results: At day 9, the percentage of cells that expressed CD45 and CD71 reached to the highest level (32.9%, IQR; 26.2-39.05) while the percentage of cells that expressed CD71 and CD235a reached to the highest level on day 17 (70.2%, IQR; 66.1-72.8). Incubation of T cells with days 14 CD71+ cells and day 21 CD71+ cells increased T cell proliferation. In a whole blood stimulation assay, day 21 CD71+ cells, but not day 14 CD71+ cells, inhibited the production of IL-6 and TNFα.

Conclusion: Cultured erythroid cells can modulate the immune response by promoting T cell proliferation and inhibiting cytokine secretions following whole blood stimulation.

Keywords: erythroid cells; immunomodulation; red blood cells; reticulocytes.

MeSH terms

  • Cells, Cultured
  • Erythrocytes
  • Erythroid Cells*
  • Humans
  • Immunity
  • Leukocytes, Mononuclear*

Substances

  • CD71 antigen